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Summary.-The blood, spleen and liver of mice were examined by means of electron
spin resonance (e.s.r.), throughout the course of myeloid leukaemia induced by
intravenous injection of leukaemic spleen cells. In blood, marked increases in
the concentrations of iron transferrin and ceruloplasmin occurred within the first
3 days after injection. In the spleen, changes in the concentrations of paramagnetic
copper and iron complexes were detectable by about the 5th day, before any measur-
able splenic enlargement, whilst in the liver changes were detectable by about
the 8th day. The changes occurring in blood, spleen and liver during the develop-
ment of leukaemia appear to be related and they are discussed in terms of iron
transport.
SINCE the first reported detection
of e.s.r. signals from biological materials
(Commoner, Townsend and Pake, 1954)
there has been considerable interest in
the differences between normal and neo-
plastic tissues. Differences have been
demonstrated in both the free radical
(e.g. Mallard and Kent, 1966, 1969) and
the paramagnetic metal (e.g. Nebert and
Mason, 1963) content of tumours and
the homologous normal tissues. How-
ever, there have been few studies of the
systemic changes which occur during the
development of malignancy (Vithayathil,
Ternberg and Commoner, 1965; Saprin et
al., 1966a, b, c; Driscoll et al., 1-967;
Swartz et al., 1973) and with the exception
of one of these (Swartz et al., 1973) they
have been confined to free radical changes.
The work reported below is part of a
programme to study changes in both the
free radicals and the paramagnetic metal
species which occur during the develop-
ment of experimental solid tumours and
leukaemias. This paper deals primarily
with changes in the paramagnetic metal
species in the organs associated with
development of a myeloid leukaemia in
mice.
MATERIALS AND METHODS
Animals.-The mice were an RF/J strain
from Okayama University Medical School,
Okayama, Japan that had been maintained
in the Paterson Laboratories for several
years. They are now designated RF/Hi.
A minimum of 6 female mice, 2-4 months
old, were used for each experimental point
and these were starved overnight before
being killed.
Inductionl andpathology ofthe leulkaemia.-
The leukaemic line was induced (Tanaka,
1969; Tanaka and Craig, 1970) by whole
body X-irradiation (400 rad, 300 kVp at
30-35 rad min-1) followed by an injection
of a leukaemic organ filtrate prepared from
RFM/Un nmice (Upton, Jenkins and Conklin,
1964). After 5 5 months a mouse manifested
marked hepatosplenomegaly with immature
cells in the peripheral blood. The leukaemia
was maintained and stabilized by serial
passage of leukaemic cell suspensions. At
this stage, an approximately six-fold increase
in spleen weight was observed, accompanied
by an increase in the peripheral blood
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6 x 104 dl-1. Differential counts from
blood smears taken at an advanced stage
of leukaemia showed about 30% of a
leukaemic myelomonocytic type of cell and
about 5000 of lymphocytes. The disease
was therefore shown to be a myeloid
leukaemia (Tanaka, 1969).
In the present experiments, leukaemia
was induced by intravenous injection of
approximately 106 leukaemic spleen cells.
A typical curve of spleen weight against
time after injection is shown in Fig. 1.
Death occurred by the 11th day after
injection.
Sample preparation.-Blood samples were
taken by cardiac puncture under ether
narcosis and immediately frozen in liquid
nitrogen into icicles 20-30 mm in length
and 3 3 mm in diameter. The liver and
spleen were excised, cut into small pieces
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and frozen into sinmilar icicles, care being
taken to avoid the inclusion of air bubbles.
All samiples were stored at -196°C in sealed,
plastic ampoules, until required for examina-
tion.
E.S.R. spectra.-The samples were exam-
ined at - 196°C in a liquid nitrogen insert
Dewar (Varian E-246) and spectra were
recorded as the first derivative of the absorp-
tion, using a Varian E-9 spectrometer with
100 kHz modulation. Quiantitative measure-
ments of peak height w,ere made by com-
parison with a standard of manganous
chloride in zinc sulphide, in a dual cavity
operating in the H014 mode. This coni-
pensated for any changes in instrumental
sensitivity with time. The incident micro-
wave power was 5 mW, except during power
saturation studies, and the mcdulation
amplitude was 10 G.
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Fie(. 1. Increase in spleen weight with time after injection of 106 leukaemic spleen cells. The
vertical lines denote standard errors.N. J. F. DODD
RESULTS
Blood
The e.s.r. spectrum of frozen blood
(Fig. 2a) shows 3 major components at
g values of approximately 6-0, 4'3 and
2*05. The broad signal at g 6-0 can
be assigned principally to methaemoglobin
(Peisach et al., 1971a). The signal at
g 4*3 is characteristic of Fe (III) in
a rhombic field. From the positions of
the 3 components it can be assigned
unambiguously toiron transferrin (Aasa et
al., 1963; Blumberg, 1967) in which the
anion binding site is occupied by bicar-
bonate (Aisen et al., 1967). The signal
at g 2-05 is due to a Cu (II) complex.
Separation of blood showed that this
signal was primarily in the plasma.
Detailed examination ofthis signal showed
the presence of hyperfine structure which
was consistent with that of the copper
g-value 6.0 4.3
containing protein, ceruloplasmin (Andre-
asson and Vanngard, 1970; Vanngard,
1974). This assignment is confirmed by
other workers (Mailer et al., 1974). Two
minor peaks are also detectable in the
spectrum of mouse blood, at g values
of 2-02 and 2-00 (Fig. 2b). The latter
is readily power saturated and can be
assigned to free radicals. The signal at
g 2-02 does not saturate so readily,
but does show considerable saturation
at 50 mW. The cause of this signal is at
present unknown.
In a control experiment, blood samples
from mice given an injection of 106
normal spleen cells showed no change in
their e.s.r. spectra over a period of 11
days. In contrast, blood samples taken
during the development of leukaemia
showed marked changes in the concentra-
tions ofiron transferrin and ceruloplasmin
200G,
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FIG. 2.-E.S.R. spectra of mouse blood recorded at-196°C. (a) 4000 gauss scan ofblood with back-
ground spectrum, recorded under identical conditions, below; (b) 400 gauss scan of g 2 region
of the blood spectrum.
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Fio. . 3.Changes in the relative heights of e.s.r. signals in blood, during the development of
leukaemia. The vertical lines denote standard errors.
(Fig. 3). The terminal stage of the
disease, in which the iron transferrin
level reaches values 2-3 times normal,
was usually marked by haematuria.
The methaemoglobin signal atg 6 00
and the free radical signal at g 2-00
showed no significant change throughout
the course of the disease. However,
a few samples of both normal and
leukaemic blood gave elevated free radical
signals. rhe magnitude of the small
signal at g , 2-02 appeared to be in-
creased between Days 5 and 7 but it is
partially masked by the larger cerulo-
plasmin signal.
Spleen
The e.s.r. spectrum of normal mouse
spleen, recorded at - 196°C (Fig. 4) shows
prominent signals at g values of ap-
proximately 6-0, 4 3, 2-04, 2-00 and 1-94.
The signal at g
- 6 can be assigned toN. J. F. DODD
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FIG. 4.-High and low field e.s.r. spectra of normal and leukaemic (Day 10) mouse spleen recorded
at - 196°C. The appropriate background spectra are also shown. The spectrometer gain was
similar to that used for the spectra in Fig. 2a.
a high-spin ferric haem compound, pos-
sibly methaemoglobin, while the signal
at g 4-3 is due to rhombic high-spin
iron. The line width of this signal is
only 50 G and it does not exhibit the
characteristic structure of the iron-trans-
ferrin-bicarbonatecomplexinblood. How-
ever, it closely resembles the signal
originally assigned to a binary complex
of Fe (III) and transferrin (Aisen et al.,
1967) but now shown to be a complex
of citrate and iron, without (Price and
Gibson, 1972), or more probably with,
transferrin (Aisen et al., 1973). The
uptake by transferrin of iron from the
spleen is believed to involve the anion
binding site of transferrin (Zschocke and
Bezkorovainy, 1974). The observed sig-
nal could arise from a species associated
with this process. Microwave power
saturation studies of the g = 2 region
showed no saturation ofthe broad g-2-04
signal, the narrow g ' 2-00 signal or the
signal at g 1-94. The g 2-04 signal
is probably due to one or more copper
complexes and the narrow g 2 00 signal
to a flavin semiquinone free radical in
the respiratory chain (Beinert and Palmer,
1965). The signal at g 1-94 is probably
due to low spin non-haem iron in an
unusual ligand field that includes a
sulphur atom (Hollocher, Solomon and
Ragland, 1966). This, like the g 2-00
signal, is located in mitochondria (Nebert
and Mason, 1963; Mallard and Kent,
1969).
During the development of leukaemia,
the signals at g -.' 2.00 and 1-94 remained
constant. Changes in the other e.s.r.
signals from spleen are shown in Fig. 5.
From Day 5 onwards, 2 new signals
with approximate g values of 6-6 and 5.1
could be detected (Fig. 4). These signals
were of approximately equal magnitude
and increased together as the leukaemia
developed (Fig. 5). It is believed that
they arise from a single entity and the
g values are consistent with those of the
high-spin ferric haem protein catalase
(Peisach et at., 1971a).
112
--.JE.S.R. STUDY DURING DEVELOPMENT OF MOUSE MYELOID LEUKAEMIA
2.
2.
g-value
x 2.04
*4.3
o6.0
o 6.6
" 1.2
.6
1.0
.2
0 2 4 6 8 10
Days after injection
FIG. 5. Changes in the relative heights of e.s.r. signals in spleen, (lurling the development of
leukaemia. The vertical lines denote standar(l errors.
Liver
The e.s.r. spectrum of normal frozen
mouse liver shows predominant signals
at approximate g values of 294, 2-25, 2-03,
2*00, 1-97, 1-94 and 1991 and smaller
ones at 6-6, 6-0, 541 and 4-3 (Fig. 6).
The signals at g values of 2-4, 2-25 and
1-91 can be assigned to cytochrome P450
(Peisach and Blumberg, 1970). Micro-
wave power saturation studies showed
the g 2-00 signal to saturate readily,
possibly indicating a major free radical
component. The signals at g values of
2-03 and 1 97 also showed saturation
at higher power (>20 mW). The signal
at a g value of 1994 is similar to that
observed in spleen and can be assigned
to a mitochondrial low-spin iron complex
(Hollocher et al., 1966; Mallard and
Kent, 1969). The signal at a g value
of 1997 has been shown to arise from
Mo(V) in a molybdoprotein of mito-
chondria (Peisach, Oltzik and Blumberg,
1971b) which is now believed to be the
molybdohaemoprotein sulphite oxidase
(Kessler et al., 1974). Both these species
may also contribute to the g 2-00
signal. The signal at g 2-03 is similar
to that reported in the liver of carcinogen
fed rats (Vithayathil et al., 1965) and in
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FIG. 6.-E.S.R. spectra of mouseliverrecorded at - 196°C. (a) 4000gauss scanof liver. Thespectro-
meter gain was half that used for the spectra in Fig. 2a; (b) 1000 gauss scan of the low field region
of the liver spectrum and the background spectrum.
the liver of untreated rats (Commoner et
al., 1970) and rabbits (Foster and Hutchi-
son, 1974), when sufficient nitrite was
present in their diet. The signal has
been assigned to an iron-NO complex
with a thiol containing protein (Woolum,
Tiezzi and Commoner, 1968), which ap-
pears to originate in the intracellular
fluid (Hutchison, Foster and Mallard,
1971). The signals at g values of 6-6
and 541 are similar to those observed in
leukaemic spleen and can be assigned to
catalase. The signal at g 4-3 is also
similar to that in spleen and is produced
by high-spin ferric iron in a rhombic
environment.
During the development ofleukaemia,
the catalase signals at g 6 6'6 and 51
and the signal at g -4 3 showed no
significant change with time. The signal
at g --' 2 03 also appeared to remain
constant, but due to its close proximity to
the large g 2'00 signal, quantitative
measurements could not be made. The
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FIG. 7. Changes in the relative heights of e.s.r. signals in liver, during the development of
leukaemia. The vertical lines dlenote standlarcd errors.
changes that occurred in the magnitude
of the signals at g values of 1-94, 1.97,
2O00 and 2-25 are shown in Fig. 7. The
other signals from cytochrome P450 at
g values of 2-4 and 1P91 changed in a
similar manner to that at 2-25.
DISCUSSION
The e.s.r. signals from mouse tissues
involved in the development of leukaemia
are summarized in the Table. These
signals arise from several different meta-
bolites and the e.s.r. technique can be
used to follow changes in their concentra-
tions. In blood, changes are recognizable
at an early stage, before any significant
increase in leucocyte count (Tanaka,
1969), splenic enlargement or detectable
leukaemic infiltration of liver or spleen
(Dodd and Giron-Conland, 1975). The
concentration of iron transferrin rises to
a maximum, within 3 days of injection,N. J. F. DODD
TABLE.-A Summary of the Major e.s.r. Signals, with Probable Assignments,
Detected in Normal Mouse Tissues
Signal
Tissue approx. g value
Blood 2- 00
2-02
2-05
4-3
6-0
Spleen 1- 94
2-00
2-04
4-3
6-0
[5-1, 6-6]
Liver 1-91, 2-25, 2-4
1 94
1-97
2-00
2-03
4-3
5-1, 6-6
6-0
Assignment
Free radicals
Unknown
Ceruloplasmin
Iron transferrin
Methaemoglobin
Mitochondrial, S-containing non-haem iron complex
Mitochondrial flavin semiquinone
Possibly a copper complex
Rhombic high spin Fe (III), possibly in a transferrin-like complex
High-spin Fe (III), possibly methaemoglobin
Catalase, in leukaemic spleen only
Cytochrome P450
Mitochondrial, S-containing non-haem iron complex
Molybdohaemoprotein, sulphite oxidase
Free radicals
Iron NO complex
Rhombic high-spin Fe (III), possibly in a transferrin-like complex
Catalase
High-spin Fe (III), possibly methaemoglobin
and this is followed, 1 or 2 days later, by
maximal ceruloplasmin levels. An early
rise and an apparently biphasic change
in ceruloplasmin concentration have pre-
viously been reported during the develop-
ment of an AKR/J myeloid leukaemia in
mice (Swartz et al., 1973). In this case
iron transferrin was not examined. In
human serum the concentration of iron
transferrin appears to be generally de-
creased in cases of malignancy, includ-
ing cancer of haematopoietic tissues
(Hughes, 1972). This is at variance
with the present findings, although in
the human studies no account is taken
of possible changes in concentration of
iron transferrin with the stage of the
disease. Iron transferrin is reported to
be decreased in iron deficiency anaemia
and certain infections, whilst it is in-
creased in haemolytic anaemia and hae-
morrhage (Owen, 1967). A decrease in
iron transferrin, with a concomitant in-
crease in ceruloplasmin, has been demon-
strated in e.s.r. studies of the blood of
rats bearing a Yoshida sarcoma (Dodd,
1975). Increases in serum concentrations
of ceruloplasmin are widely reported
in cases of human leukaemia, lymphoma
and Hodgkin's disease (Warren et al.,
1969; Hrgovcic et al., 1968, 1973a, b, c;
Tessmer et al., 1972, 1973a, b; Jelliffe,
1973) and in other malignant diseases
(Hughes, 1972). Recently e.s.r. has been
used to demonstrate similar increases in
the blood of patients with Hodgkin's
disease and with cancers of the breast
(Foster et al., 1973) and to study the
effects of radiotherapy on plasma cerulo-
plasmin concentrations in a variety of
cancer patients (Swartz and Wiesner,
1972). However, serum ceruloplasmin
concentrations also increase during preg-
nancy, acute and chronic infections,
collagen disorders and myocardial infarc-
tion, following surgery and after adminis-
tration of oestrogens and thyroid and
pituitary hormones (Hrgovcic etal., 1973c;
Hughes, 1972; Owen, 1967).
Changes in the concentrations of
individual plasma proteins are therefore
not specific to leukaemia or even to
malignant diseases, although some rela-
tionship appears to exist between the
concentrations of ceruloplasmin and iron
transferrin in blood. The nature of this
relationship is influenced by the disease,
e.g. a parallel relationship in myeloid
leukaemia and an anti-parallel relationship
in Yoshida sarcoma, and a study of this
relationship may lead to a better under-
standing of the biochemistry of its de-
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velopment. Ceruloplasmin transports
copper through the body but a more
important role may be its ferroxidase
activity (Osaki, Johnson and Frieden,
1966; McDermott et al., 1968; Frieden,
1971). This appears tc be essential to
the utilization of Fe(II) bv tranisferrin.
Here therefore is a direct link between
ceruloplasmin and iron transferrin.
In the myeloid leukaemia studied
here, the increased uptake of iron by
plasma, indicated by the initial increase
in iron transferrin, is assisted by the
concomitant increase in ceruloplasmini.
The cause of this increase in iron uptake
is at present unclear. It may result from
increased haemoglobin catabolism. Since
iron is also important in the mitotic
process and since transferrin promotes the
growth of lymphocytes (Tormey, Imrie
and Mueller, 1972; Tormey and Mueller,
1972), the increase in signal may be
associated with the increase in white
blood cells and growth of leukaemic cells
in the spleen.
The role of transferrin is primarily
the distribution of iron between organs
taking part in iron metabolism (Zschocke
aind Bezkorovainy, 1974). Changes in
plasma iron transferrin and ceruloplasmin
may therefore be linked with changes in
other organs. The biphasic changes in
the blood show a superficial correlation
with the changes occurring first in the
spleen and then in the liver. However,
any deductions are speculative at present.
The fall in ceruloplasmin and iron trans-
ferrin in the blood of leukaemic mice,
which occurs between Days 4 and 6,
coincides with the fall in the g ' 4-3
iron and g , 2-04 copper signals in the
spleen. This may represent a change
in the form or oxidation state of the
metals, either as they are utilized within,
or removed from-, the spleen. The ab-
sense of any detectable change in the
mitochondrial e.s.r. signals (g
- 2-00 and
1.94) of the spleen suggests that the
changes occurring are not associated with
increased mitochondrial activity. If the
spleen signal at g
- 4 3 represents " avail-
able iron" in a transferrin-like complex,
as suggested above, its depletioii in the
spleen could result in the observed fall
in iron transferrin in the blood. The
elevated ceruloplasmin seen on Day 5
may be an attempt to maintain plasma
iron levels.
The cause of the appearance of a
catalase signal in leukaemic spleen and
the decay of the signal from other high-
spinl ferric haem compounds is not known.
Examination of other myeloid leukaemias
(RFM/Un, AKR/J and P388) failed to
show this effect.
The second increase in iron transferrin
and ceruloplasmin in the blood occurs
on about Day 8 ofleukaemic development.
This coincides with changes in the liver,
viz. a decrease in the magnitude of
signals from cvtochrome P450 and, unlike
spleen, the mitochondrial signals at ap-
proximate g values of 1P94 and 2-00.
These changes may represent a change
in the form or oxidation state of iron
either as it is utilized within the liver or
is removed by the blood. Changes in
the level of cytochrome P450 in the liver
may also be related to changes in the
copper status of the spleen. The increase
in catalase in leukaemic spleen is not
paralleled in liver.
The terminal stage of leukaemia (Days
10 and 11) is marked by a massive
increase in iron transferrin and a decrease
in ceruloplasnmin in the blood. The
former appears to be associated with
haemorrhage, while the latter may be
part of the general decline in activity
associated with morbidity.
Parallel studies on wet tissues from
these leukaemic mice (Dodd and Giron-
Conland, 1975) have shown changes in
the concentration of ascorbyl radicals in
spleen and liver during the development
of leukaemia. The ascorbyl radical con-
centration in spleen reaches a maximum
as the copper and iron signals decrease
in magnitude. In liver the ascorbyl
radical concentration increases as the
signals at g values of 1-94, 2-00 and 2-25
decrease. Ceruloplasmin has been shown118 N. J. F. DODD
to exhibit ascorbate oxidase activity
(Frieden, McDermott and Osaki, 1965)
and, although not generally accepted
(Aisen, 1974) it has been postulated that
ascorbic acid is intimately involved in
iron transport (Mazur, Green and Carleton,
1960; Osaki et al., 1966). The increase in
ascorbyl radical concentration in both
spleen and liver might indicate reduction
of Fe(III) to Fe(II) and possibly subse-
quent removal of iron from the tissues.
The e.s.r. results indicate that the
observed changes in organs of leukaemic
mice may be inter-related, representing
different aspects of iron transport. Much
work is still necessary to identify all
the species involved and to determine
their site of action within the cell. It is
believed that e.s.r. can, in future, help
to elucidate some of the biochemical
events involved in the development of
malignant disease. A change in one
particular biochemical species may have
many different causes but simultaneous
examination of several species may give
specific information. For example,
changes in ceruloplasmin during the
course of Hodgkin's disease have long
found limited clinical application, but
it now appears that simultaneous deter-
mination of ceruloplasmin and iron trans-
ferrin gives a more reliable guide to
patient status (Foster, unpublished).
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